Cannabis Research Institute
About CRI
Cannabis Research Institute aims to be an unbiased, rigorous, equity-centric research center advancing public knowledge about all aspects of cannabis and hemp. Key research priorities for CRI include agricultural crop management, health and medicinal effects, and social equity impacts.
The institute launched July 1, 2024 with support from the Illinois Department of Human Services and sponsorship from the Illinois Cannabis Regulation Oversight Office.
Meet the director of CRI
Reginald Gaudino
Dr. Reginald “Reggie” Gaudino has joined DPI as the inaugural Director of the Cannabis Research Institute. A molecular geneticist specializing in biochemical networks in plant phytochemistry, Reggie brings over 20 years of experience as a patent scientist at several national law firms before transitioning to cannabis research. In 2014, he joined Steep Hill, where he leveraged his deep understanding of intellectual property (IP) to lead a team in developing the first DNA-based diagnostic assay for cannabis within a year. His work resulted in multiple patents and paved the way for his move to Front Range Biosciences in 2019 as Vice President of R&D and Director of IP. At Front Range, Reggie led a team of 20 scientists, agronomists, breeders, and growers in sophisticated breeding programs, driven by multidisciplinary scientific support, all while advancing cannabis research.
CRI riverside chat
CRI was celebrated with a kick-off reception and panel discussion in November, 2024. The recording “CRI: From Seed to Social Impact” is now available.
Stay informed!
Click below to subscribe and stay up-to-date on the latest cannabis research.